Truth Of The MMR Vaccine Scandal

truth of the mmr vaccine scandal_They travelled to London in the mid-1990s, each carrying or pushing a child. A dozen anonymous families with 11 boys and one girl, who were to trigger the health scare of our time. The children had brain disorders. Some had autism; others, Asperger’s or epilepsy. And nearly all of the parents had come to believe that the cause was the measles, mumps and rubella (MMR) vaccine.

I think it was I who later dubbed them “the Lancet 12”, after the medical journal from which they leapt into the headlines. Written up in February 1998 by Dr Andrew Wakefield and other doctors at the Royal Free hospital, in north London, their cases at first appeared to provide credible grounds for the panic that took off over the vaccine.

Whether or not I named them, the moniker has stuck. And over the past 2½ years, in a central London committee room, their numbers have been called like pedalos in the park during the longest medical misconduct inquiry ever held.

“Now, sir, Child 5 … If the panel would turn to Child 9 … We’ll resume with Child 4 after lunch . . .”

With each call of a number, at the West End offices of the General Medical Council (GMC), lever-arch files have been yanked from cardboard crates. Front covers have been lifted. Tabs pulled. And then five QCs, five disciplinary panel members, the three doctors under investigation and a witness have together located a page — say, a GP’s note from 1996 — to be read aloud.

“Mum taking her to Dr Wakefield, Royal Free hospital, for CT scan, gut biopsies, query Crohn’s. Will need ref letter. Dr Wakefield to phone me.”

Throughout 29 widely spaced weeks of evidence and submissions, such notes have been pored over like the Dead Sea scrolls. What was wrong with these children? Why were they brought to the Royal Free? How did their medical problems end up in The Lancet?

I can answer all of that. I can name the 12 from memory. They’ve been part of my mental landscape for half a decade. As the reporter whose investigations exposed the flaws in Wakefield’s research and sparked this unprecedented inquiry, I’ve sometimes felt that these kids and I were mysteriously in it together, like the passengers on the Orient Express.

Most of their parents would be outraged by the idea: some of the mothers have grown to hate me like satan. I’m the man who pulled the rug from under the idea that, however painful, helped them to make sense of their world, and I feel for their grief.

This week, more of the saga of MMR will unfold, with “findings of fact” on who did what at the hospital. After nearly 200 days (the trial of OJ Simpson lasted 134), a panel of three doctors and two lay members will open the latest, but not the last, chapter in the story, with rulings on a raft of extraordinary charges of professional misconduct.

Strenuously denying them are three of the men whose Lancet report set off a tsunami of anxiety in 1998. That report claimed that within days of receiving MMR, eight of the 12 children showed the first signs of what was called “regressive autism”, and 11 later developed bowel disease.

At the time, the three doctors were consultants at the Royal Free, where the kids were brought for a battery of investigations. John Walker-Smith, now 73, was the most senior. He was professor of paediatric gastroenterology. Short and white-haired, with his voice betraying Australian origins, he has seemed to age as each lever-arch file has flopped open.

To his right at the hearing was Simon Murch, 53, a paediatrician whose speciality was colonoscopies. Tall and languid, he’s now a professor at Warwick University and, as the mammoth hearing has progressed, he has written and selfpublished a novel about old chums going boating on the Thames.

The sharpest spotlight was on Andrew Wakefield, 53, who sat to their left, amid a phalanx of barristers and solicitors. In the 1990s he was a researcher in the Royal Free’s medical school. And for two years before the Lancet report, at £150 an hour, he had been helping a Norfolk lawyer to gather evidence about MMR for a planned lawsuit against its manufacturer.

A former trainee gut surgeon and champion amateur rugby player, Wakefield had double Walker-Smith’s presence. He was quizzed for 22 days but called no witnesses. Then he flew to Austin, Texas, where he now runs an autism clinic, and arrived back in London last Wednesday morning.

I suppose I might call them “the MMR Three”. But, after breaking innumerable stories on how the vaccine scare was contrived, I found the doctors — like the hearing room’s dry air and ochre carpet — less memorable than the stories of the 12.

The first, Child 1, was a little boy from Lincolnshire. His mother brought him to the hospital in July 1996, when he was just 3½ years old. He was autistic, like his brother. After being admitted to a sixth-floor ward, he endured five gruelling days of tests, in what appears to have been a hunt for vaccine damage.

The other 11 kids were brought in over the following seven months: a sporadic, sad procession of broken dreams. Some were severely retarded and irrevocably autistic. None was from London. Two were brothers. One was American. Two were registered at the same GP surgery on Tyneside. Three were patients at another hospital clinic.

I’ve met many of their parents, and even some of the children. The most memorable was the American: Child 11. Now a dark-haired teenager, he recently came over for Wimbledon fortnight.

All 12 underwent similar procedures. They had an ileocolonoscopy under anaesthetic — a method of inspecting the bowel. It is a rare investigation in children, listed in ethical guidelines as “high risk”. Nearly all had lumbar punctures, MRIs and EEGs.

What was going on here? The Royal Free had no department of, and little expertise in, children’s development disorders. The GMC’s case is that the 12 were enrolled in unapproved medical research. It says Wakefield’s mission was to find evidence, in gut tissue and brain fluid, to prove a theory about how MMR could cause autism.

That theory, now discredited, proposed that autism and bowel disease were caused by the measles virus, found in the vaccine. And to show this, the council says, Wakefield wanted to examine children’s bowels and other organs.

“No one doubts or has questioned the tragedy of these children’s disorders, nor the love of their parents,” Sally Smith QC told the panel last March, closing the council’s submissions. “But this case is about the nature of the doctors’ duties towards their patients. And, of course, it is the child who is the patient in every case.”

In addition, she said, the hearing was about the reporting of research: the “accuracy and honesty and transparency” of the Lancet report. And third, she told the panel, chaired by a GP, Dr Surendra Kumar, it was about “conflicts of interest” on Wakefield’s part. “It’s a case about breaches of some of the most fundamental rules in medicine,” she said.

These are among the gravest professional charges any doctor can face, striking at the heart of medical ethics. After Germany’s experience in the second world war, volumes of regulations have evolved to protect patients, especially children, from any possibility of being treated as guinea pigs.

Against the council’s case, Wakefield and his colleagues say the tests on the 12 were solely in the children’s interests. Although no Royal Free witness or document verified this narrative, the doctors each assured the panel that every investigation, every blood test, was part of the children’s normal clinical care.

“Dr Wakefield had a profound interest in, and concern for, these children, many of whom were known to him as a result of initial contact by the parents,” said Kieran Coonan QC, Wakefield’s lawyer, closing his remarks.

Only one parent sat in the witness chair: the mother of Child 12, who had spoken of her grief on being persuaded, in the summer of 1996, that the child’s condition could be due to the vaccine. She gave evidence to the hearing back in August 2007, although she stressed that her six-year-old son was kindly treated. She had originally gone to Wakefield after contact with an MMR campaigner and the Norfolk lawyer Wakefield was working with, four years after the boy received his shot.

On Thursday this week the panel is expected to give its judgments. Vaccine safety will be back in the news. Not the old chestnut about whether MMR causes autism: this time the debate will be about the extent to which those who proposed the link can or cannot be trusted.

As for the Lancet 12 themselves, they are now young adults. Only one came, briefly, to listen. Others are in institutions, either full-time or during the week. Just a handful might comprehend their place in history.

What was reported on these children in 1998 triggered an epidemic of fear. But there have been other — forgotten — victims of the scare: the parents, who for years believed it was their own fault that a son or daughter had a brain disorder. The debate over MMR stalks their souls.

Before vaccination, their children appeared healthy and happy. Some time afterwards, there were signs of a problem and parents were led to believe it was caused by the vaccine. “I had this perfectly normal child,” said Mrs 12, giving evidence. “It was like a jigsaw puzzle that seemed to fit into place.” More of the picture will be visible on Thursday. By Brian Deer, The Sunday Times

Obesity Gene Discovery ‘May Cut Cases Blamed On Abuse’

obesity gene discovery_Scientists have discovered what they believe is a genetic cause of severe obesity in children.

The team concluded that the loss of a key segment of DNA can be to blame.

It said the findings might improve diagnosis of severe obesity – which on occasion has been wrongly attributed to abusive overfeeding.

The study, of 300 children with severe obesity by the University of Cambridge and the Wellcome Trust Sanger Institute, appears in Nature.

Some of the children in the study had been formally placed on the social services ‘at risk’ register on the assumption that their parents were deliberately overfeeding them. They have now been removed from the register.

Obesity is increasing throughout the world and is recognised as a major global public health concern.

Although much of the problem is due to lifestyle factors such as an unhealthy diet, and lack of exercise, some cases are thought to be down to genetics.

The latest study examined each child’s entire genome, looking for deletions or duplications of DNA, known as copy number variants (CNVs).

Experts increasingly believe these CNVs play an important role in genetic disease.

Genome scan

By comparing the DNA profile of obese children with others of a normal weight they found certain parts of the genome were missing in the obese group.

In particular they zeroed in on a missing part of chromosome 16 which seemed to have a strong link to severe obesity.

Researcher Dr Sadaf Farooqi said: “Our results suggest that one particular gene on chromosome 16 called SH2B1 plays a key role in regulating weight and also in handling blood sugar levels.

“People with deletions involving this gene had a strong drive to eat and gained weight very easily.

“It adds to the growing weight of evidence that a wide range of genetic variants can produce a strong drive to eat.

“We hope that this will alter attitudes and practices amongst those with professional responsibility for the health and well-being of children.”

Dr Matt Hurles, who also worked on the study, said: “This is the first evidence that copy number variants have been linked to a metabolic condition such as obesity.

“They are already known to cause other disorders such as autism and learning difficulties.”

Dr Ian Campbell, medical director of the charity Weight Concern, stressed most children did not have significant genetic factors that predisposed them to obesity, and that lifestyle, diet and exercise remained important.

But he added that the causes of obesity – and the potential solutions – were complex.

He said: “The fact that several of the study children have been taken out of social care and returned to their parents as a result is disturbing in itself and must surely put an end to the claims by some that childhood obesity is a simple case of parental abuse. “It clearly isn’t. These families need our support.”  BBC News

Restaurant Hit By Virus Reopens

restaurant hit by virus reopens_A Michelin-starred restaurant which closed after more than 80 diners became ill has reopened.

Several staff at The Star Inn in Harome were also taken ill with the vomiting bug norovirus, the Health Protection Agency (HPA) said.

The cause of the illness has not yet been confirmed by the HPA.

Owners Jacquie and Andrew Pern said the restaurant reopened on Monday evening following “extensive, precautionary sanitisation procedures”.

Mrs Pern said: “We have taken advice from Ryedale Council and the Health Protection Agency in this respect and exceeded all of their recommendations.”

The restaurant closed voluntarily on 2 November after more than 80 people developed symptoms after eating there between 18 and 28 October, the HPA said.

Norovirus causes nausea, vomiting and diarrhoea and is also known as the winter vomiting virus. BBC News

Treating Mild Diabetes During Pregnancy Beneficial

treating mild diabetes during pregnancy beneficial_Treating even mild diabetes that develops during pregnancy helps keep moms and babies from gaining too much weight and makes for easier deliveries, new research shows.

Pregnant women in the U.S. are routinely tested and treated for high blood sugar levels, although it hasn’t been clear whether treating the mildest cases really benefited them and their infants.

In a study of 950 women, those with mild gestational diabetes who were treated had fewer overly large babies, fewer cesarean sections and fewer pregnancy complications, compared to women who didn’t have their diabetes treated.

“There is every reason to fully treat women with even the mildest (gestational diabetes) based on our results,” said the study’s leader, Dr. Mark Landon of Ohio State University Medical Center in Columbus.

Gestational diabetes begins during pregnancy and usually goes away after childbirth. It affects as many as one in seven pregnant women, depending on the population. The mother’s elevated blood sugar can cause the fetus to grow too large, sometimes requiring a C-section and can bring on other health problems for the mother and baby.

Risk factors include being over 25, being obese and a family history of diabetes.

Medical groups support testing pregnant women for the condition and treatment, although the U.S. Preventive Services Task Force, a government health panel, said last year there wasn’t enough evidence to recommend screening.

Landon said he’d had doubts about treating mild cases, and was surprised by the study’s results.

“I did it, yet I wondered, ‘Was I overtreating?’” he said.

For the government-funded study, 958 women with mild gestational diabetes were recruited at 15 medical centers. They got either diabetes treatment or standard prenatal care. Treatment included diet counseling and insulin if needed to get their blood sugar under control.

In the treatment group, there were fewer babies of unusually large size (7 percent vs. 15 percent in the untreated group) and fewer babies weighed more than about 9 pounds (6 percent vs. 14 percent). On average, the treated women gained 5 fewer pounds after their diagnosis than the untreated ones.

There were also fewer C-sections and cases of preeclampsia, a serious pregnancy complication. There were no deaths in either group, and no difference in other birth-related complications.

Landon noted that a “remarkable” 93 percent of the women in the treatment group kept their blood sugar under control with diet alone; only 7 percent needed insulin.

The findings are reported in Thursday’s New England Journal of Medicine.

Dr. David A. Sacks of Kaiser Foundation Hospital in Bellflower, Calif., said switching to a healthier diet could help other pregnant women limit weight gain, too. More large babies are born to overweight or obese women who don’t have diabetes, he said.

“This is a real easy therapy to apply to every single pregnant lady,” said Sacks, who wrote an editorial about the study in the journal.

Even before she got pregnant, Lorenda Donaugh knew all about gestational diabetes. She works with Landon at Ohio State, doing ultrasounds for his patients, and ended up becoming one after she was diagnosed at 28 weeks with a mild case.

“I knew it was going to be hard work. It takes a lot of time and planning,” said the 27-year-old, who lives in the Columbus suburb of Westerville.

Donaugh, who was not part of the study, monitored her blood sugar several times a day, modified her diet and took extra walks. She eventually took a diabetes medication.

Planning meals and cutting back on sugar was the hardest part, she said. Whenever she was tempted, she thought of her baby. “Being pregnant, you have all those cravings, but you still have to limit that food,” she said.

The work paid off. She delivered a healthy daughter on Sept. 14. Adelynn weighed 6 pounds, 4 ounces and her mom had only gained a modest 22 pounds. Khaleej Times

Study Reveals Fish Intake Doesn’t Stop Heart Failure

study reveals fish intake doesn't stop heart failure_A new Dutch study reveals that fish does not seem to guard against the development of heart failure, though eating fish appear to protect one against heart attacks and other cardiovascular disease.

Heart failure is a degenerative condition, but with the right treatment and lifestyle people are living longer with it.

In fact, some 5.7 million Americans are living with heart failure, and 670,000 new cases are diagnosed each year, according to the American Heart Association.

“We examined whether the intake of fish and its omega-3 fatty acids could protect against the development of heart failure in people who had no history of coronary heart disease,” said lead researcher J. Marianne Geleijnse, an assistant professor of epidemiology at Wageningen University.

“However, we found no association except for a possible protective effect of omega-3 fatty acids against heart failure in a subgroup with diabetes”, Geleijnse added.

There is strong evidence for a general cardioprotective effect of omega-3 fatty acids from fish, although the underlying mechanisms are not yet clear, Geleijnse said. The report is published in the October issue of the European Journal of Heart Failure.

For the study, Geleijnse’s team collected data on 5,299 men and women who participated in the Rotterdam Study.

The researchers wanted to see if the omega-3 fatty acids in fish could protect people from developing heart failure as they appear to protect people from other types of heart trouble.

Over almost 12 years of follow-up, the researchers found that 669 people developed heart failure.

Geleijnse’s group found that eating fish rich in omega-3 fatty acids was not significantly related to developing heart failure in either men or women.

Both types of these acids the researchers looked at (EPA and DHA) have been linked to reduced blood pressure, heart rate, arrhythmias and triglyceride levels, all of which are associated with risk of heart attack and heart disease.

However, there did seem to be a small benefit in the reduction of heart failure among diabetics who ate the most fish, Geleijnse noted.

“It is worthwhile to further examine whether dietary intake of omega-3 fatty acids could reduce the risk of heart failure in diabetics,” she said.

“Fish intake may not influence risk of heart failure, but there is strong evidence that it protects against myocardial infarction, sudden cardiac death and stroke,” Geleijnse stated. “Therefore, it is wise to consume fish twice per week, in particular fatty fish like salmon, herring and mackerel.”

Dr. Gregg C. Fonarow, a professor of cardiology at the David Geffen School of Medicine at the University of California, Los Angeles, said that “heart failure results in substantial morbidity, mortality and health-care expenditures. Finding effective strategies to prevent heart failure is a very high priority.”

Clinical trials have shown that supplementation with certain formulations of omega-3 fatty acids reduce the risk of recurrent cardiovascular disease and produce modest improvements in survival in patients with established heart failure, Fonarow said.
“A prior observational study suggested that, among older adults in the U.S., dietary consumption of fish was associated with a lower incidence of heart failure,” he said. “This new observational study conducted in the Netherlands did not find that self-reported dietary consumption of fish at higher levels was associated with a lower risk of heart failure,” Fonarow explained.

“Only prospective randomized placebo-controlled clinical trials will be able to definitively establish whether or not omega-3 fatty acid supplementation reduces the risk of new-onset heart failure,” Fonarow said. “Such studies are now ongoing.”

Dr David L. Katz, director of the Prevention Research Center at Yale University School of Medicine, added that “we have abundant evidence that fish consumption is good for health overall and cardiovascular health in particular. This study doesn’t change that.”

Even in this study, the trend for fish intake was favorable with slightly less heart failure in those consuming the most, he said.

“We should expect that the incremental contribution of fish to health is modest. Fish can contribute to your health, and that of your heart, but do so most reliably in the context of healthful living,” Katz said. By Joy Online.

Killer Prostate Cancer Test Hope

prostate cancer_Scientists have discovered a protein that predicts survival from prostate cancer at diagnosis. A University of Liverpool team found the presence of heat shock protein-27 (Hsp-27) was a key marker of how prostate cancer would progress.

Men who tested positive for Hsp-27 at diagnosis were almost twice as likely to die from the disease in the next 15 years than those who did not.

The study features in the British Journal of Cancer. Aggressive prostate cancer can kill rapidly, and requires immediate treatment.

However, prostate tumours can also be very slow-growing, and people who develop them often end up dying of unrelated conditions.

It can be difficult to distinguish between the two forms of the disease, and consequently many men end up unnecessarily undergoing intensive treatment which carries a risk of side effects.

The Liverpool team analysed tissue samples taken from 553 men at the time they were diagnosed with prostate cancer.

Their findings suggest testing for Hsp-27 might be a more reliable way of determining whether a tumour is aggressive or not.

Lead researcher Professor Chris Foster said: “Our study shows that this protein marker can give us a reliable and accurate indication of whether individual cancers will become aggressive.

“Currently, we are working on developing this finding into a blood test to monitor men with prostate cancer in order to determine when their individual disease needs treatment.” Hsp-27 is a key component of signalling pathways that control the movement of cells around the body.

The study also suggests that new drugs could be developed to block these signals and halt the spread of prostate cancer cells.

Important step

Dr Lesley Walker, director of cancer information at the charity Cancer Research UK, said: “These results are an important step towards tackling the long-standing question of how to treat men with prostate cancer once it has been diagnosed.

“The need for treatment varies greatly between patients – men with non-aggressive cancer can live with it for many years without needing therapy, while aggressive cancers require prompt treatment with combinations of surgery, radiotherapy and chemotherapy.

“A marker molecule which identifies aggressive prostate cancer would help us target active treatment to patients who need it – avoiding unnecessary therapy, which can have side effects, to those who don’t.”

Jon Neate, chief executive of the Prostate Cancer Charity, said much research was under way to try to develop a more accurate diagnostic test.

He said: “It is critically important to develop a test for prostate cancer which is able to distinguish reliably between aggressive and slow growing forms of the disease.”

Prostate cancer is the most common cancer in men in the UK, with about 34,000 new cases diagnosed every year.

About 10,000 men die from the disease each year in the UK. Several tests are currently used to diagnose prostate cancer, including testing for levels of a protein called prostate-specific antigen (PSA).

A high level of PSA can be a sign of cancer – but average levels tend to rise with age, and so the test can be unreliable. BBC News.

Saudi Foreign Minister’s Spinal Surgery In US Successful

saudi foreign minister's spinal surgey in u.s. successful_Saudi Arabia has announced that its long serving foreign minister had successful spinal surgery in the United States.

The state news agency reported late Saturday that Prince Saud al-Faisal had surgery on the vertebrae in his neck and will return home upon full recovery.

Prince Saud, who is in his 70s now, is the eldest son of the late King Faisal bin Abdul-Aziz, and lately had been suffering from back problems.

He became foreign minister in 1975. Prior to that he was the kingdom’s oil minister. AP.